Global Defibrillator Market Analysis

$3,000.00$7,500.00

  • Type: Service area
  • Published : March 2022
  • Region: Worldwide
  • Country: Other
  • Report ID : 5117

  • Format: PPT, PDF

Global Defibrillator Market: Segmented by Product Type, Patient Type, End User Type, and Regional Type – Growth, Market Size, Future Prospects & Competitive Analysis, 2021 – 2028

Clear
SKU: 5117 Categories: ,

Report Description of the Global Defibrillator Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of Global Defibrillator  market
  • To classify and forecast Global Defibrillator  market based on application, drugs, project type, and application.
  • To identify drivers and challenges for Global Defibrillator market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in Global Defibrillator market
  • To conduct pricing analysis for Global Defibrillator market
  • To identify and analyze the profile of leading players operating in Global Defibrillator market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for oncology  drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the oncology drug market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

Global Defibrillator Market Executive Summary

According to data published by the National Institutes of Health in 2016, an estimated 450,000 people suffer due to sudden cardiac death. Since the prevalence and incidence of out-of-hospital cardiac arrest are increasing, developed as well as emerging nations are strictly focusing on installations of external defibrillators in public places such as schools, hotels, shopping malls, streets, and others. Combined with this, education is being offered in schools to spread awareness about them amongst children with the aim to deal with cardiac arrests, which is expected to offer a significant amount of opportunity for the growth of the defibrillator market by 2026

Market Size and Key Findings

The Global Defibrillator market size is at around USD 11.4 billion in 2021 and is projected to reach USD 18.2 billion in 2026, exhibiting a CAGR of 9.7% during the forecast period.

The rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs & CRT-Ds are expected to offer growth opportunities for players in the defibrillators market.

Market Dynamics

Market Growth Drivers Analysis

Growing focus towards public access defibrillator (PAD) by the public and private organizations has fueled the market growth. Moreover, increase in number of key players to develop advanced defibrillator devices, rapidly growing geriatric population with elevated risk of cardiac arrest and increase in incidence of cardiac diseases further drive the market growth. Defibrillators are capable of performing cardioversion, defibrillation, and pacing of the heart. External defibrillators are of three major types, namely manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs). AEDs are used for the treatment of sudden cardiac arrest (SCA) due to its high efficiency and ease in use, thereby bagging a large market share in the global defibrillator market.

Market Restraints

Issues related to the use of implantable and automated external defibrillators like  AEDs installed in public places are sometimes prone to failure due to problems pertaining to the battery, software, and hardware and cybersecurity concerns are major concern in the defibrillators market. Furthermore, increase in pricing pressure on players is restraining the growth of the defibrillators market. anticipated to obstruct growth.

COVID-19 impact on “Global Defibrillator Market”

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global defibrillators market. The outbreak of COVID-19 has disrupted workflows in the healthcare sector globally. The pandemic affected the buying capacities of hospitals, particularly in small-scale hospitals, resulting in canceled or postponed supply deals and procedure, which has impacted the overall revenue of all the major players in the defibrillators market.

Competitive Landscape

Key Players

Prominent players in the defibrillators market include Medtronic (Ireland), Stryker Corporation (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), Nihon Kohden (Japan), MicroPort (China), BIOTRONIK (Germany), CU Medical Systems (South Korea), METsis Medikal (Turkey), Mediana Co. Ltd. (Korea), Mindray Medical International Ltd. (China), Progetti SRL Medical Equipment Solutions (Italy), and Schiller AG (Switzerland).

Products in Pipeline

REFINE-ICD: GE Healthcare

The product is in pipeline to evaluate whether an implantable defibrillator will increase the likelihood of survival in patients who have had a heart attack in the prior 5 years, have abnormal test results from a 24 hour heart monitor, and who have low normal heart function. The REFINE ICD trial will assess whether prophylactic ICD therapy, guided by non-invasive risk assessment tools, reduces mortality in MI survivors with better-preserved LV function. The study is estimated to be complete by December 2021.

MADIT S-ICD: Boston Scientific Corporation

The MADIT S-ICD trial is designed to evaluate if subjects with a prior myocardial infarction, diabetes mellitus and a relatively preserved ejection fraction of 36-50% will have a survival benefit from receiving a subcutaneous implantable cardioverter defibrillator (S-ICD) when compared to those receiving conventional medical therapy. The study is estimated to be completed by December 2023.

Notable Recent Deals

July 2021-ZOLL Medical Corporation, announced that the company has received clearance from FDA 510(k) to release the TBI (traumatic brain injury) Dashboard feature on its Propaq M monitor and Propaq MD defibrillator. This feature provides clinical decision support for managing patients with TBI and was available in international markets but with the FDA clearance it is now available in U.S. market.

March 2021- The Rankin government made an announcement that all public schools in Nova Scotia a will be provided automated external defibrillators. The government made an investment of USD 700,000. The purpose of this investment is the availability of these devices at the time of cardiac emergency.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of Global Defibrillator Services

Centers for Medicare and Medicaid Services(CMS), which is a part of the US department of health and human services, provides reimbursement for the wearable defibrillator across a number of high-risk patient groups.

The U.S. Food and Drug Administration issued several regulations on AEDs, including required premarket approval for new and existing AEDs (2015) and necessary accessories (2020) after reports of failing or malfunctioning devices. Some issues were due to manufacturing problems, while others were due to improper maintenance such as battery failure.

1. Report Description of the Global Defibrillator Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Global Defibrillator Market Executive Summary
2.1 Global Defibrillator Market – Industry Snapshot & key buying criteria, 2021-2026
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Global Defibrillator Market
3.1 Market Growth Drivers Analysis
3.1.1 Growing focus towards public access defibrillator (PAD) by the public and private organizations
3.1.2 Increase in number of key players to develop advanced defibrillator devices
3.1.3 Rapidly growing geriatric population
3.1.4 Increase risk of cardiac arrest and increase in incidence of cardiac diseases
3.2 Market Restraints Analysis
3.2.1 Issues related to the use of implantable and automated external defibrillators
3.2.2 Increase in pricing pressure on players
3.3 Covid-19 Market Impact Analysis
3.3.1 Negative impact on outcomes
4. Global Defibrillator Market Segmentation
4.1 By Product Type Analysis:
4.1.1 Implantable Cardioverter Defibrillators
4.1.2 External Defibrillators
4.2 By Patient Type Analysis:
4.2.1 Adult
4.2.2 Pediatric
4.3 By End User Analysis:
4.3.1 Hospitals
4.3.2 Clinics and Cardiac Centers
4.3.3 Prehospital Care Settings
4.3.4 Public-access markets
4.3.5 Alternate care facilities
4.3.6 Home care settings
4.3.7 Others
4.4 By Regional Analysis:
4.4.1 North America
4.4.1.1 US
4.4.1.2 Canada
4.4.2 Europe
4.4.2.1 Germany
4.4.2.2 UK
4.4.2.3 France
4.4.2.4 Italy
4.4.2.5 Spain
4.4.3 Asia Pacific
4.4.3.1 Japan
4.4.3.2 China
4.4.3.3 India
4.4.3.4 South Korea
4.4.3.5 Singapore
4.4.3.6 Australia
4.4.4 LAMEA
4.4.4.1 Brazil
4.4.4.2 Argentina
4.4.4.3 Israel
4.4.4.4 Egypt
4.4.4.5 South Africa
4.4.4.6 Rest of LAMEA
5. Global Defibrillator Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Global Defibrillator Market
6.4 Notable recent deals in Global Defibrillator Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers &Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Medtronic Company Overview
Product & Services, Strategies & Financials
7.2 Stryker Corporation Company Overview
Product & Services, Strategies & Financials
7.3 Koninklijke Philips N.V. Company Overview
Product & Services, Strategies & Financials
7.4 Asahi Kasei Corporation Company Overview
Product & Services, Strategies & Financials
7.5 Boston Scientific Corporation Company Overview
Product & Services, Strategies & Financials
7.6 Nihon Kohden Company Overview
Product & Services, Strategies & Financials
7.7 MicroPort Company Overview
Product & Services, Strategies & Financials
7.8 BIOTRONIK Corporation Company Overview
Product & Services, Strategies & Financials
7.9 CU Medical Systems Overview
Product & Services, Strategies & Financials
7.10 METsis Medikal Company Overview
Product & Services, Strategies & Financials
7.11 Mediana Co. Ltd. Company Overview
Product & Services, Strategies & Financials
7.12 Medical International Ltd. Company Overview
Product & Services, Strategies & Financials
7.13 Progetti SRL – Medical Equipment Solutions Company Overview
Product & Services, Strategies & Financials
7.14 Schiller AG Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of Global Defibrillator Market
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development Global Defibrillator Market
9.2 Future Opportunities
10. Strategic Recommendations

Defibrillator Market Segmentation

By Product Type :

Based on product type, the defibrillator market is segmented into implantable cardioverter defibrillators and external defibrillators. The implantable cardioverter defibrillator (ICDs) segment is expected to dominate this market during the forecast period. The large share of this market segment can be attributed to the increasing prevalence of cardiovascular diseases and the development of technologically advanced defibrillators

  • Implantable Cardioverter Defibrillators
  • External defibrillators.

By Patient Type :

Based on patient types, the defibrillator market is segmented into adult  and pediatric. The adult patient segment segment accounted for the largest market share in 2020. The adult patients segment dominated the global defibrillators market with a share of 59.5% in 2020.

  • Adults
  • Pediatric

By End Users :

Based on end users, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; prehospital care settings; public-access markets; alternate care facilities; home care settings; and other end users. The hospitals, clinics, and cardiac centers segment dominated the global defibrillators market, with a share of 80.2%, in 2020.

  • Hospitals
  • Clinics and Cardiac Centers
  • Prehospital Care Settings
  • Public-access Markets
  • Alternate Care Facilities
  • Home Care Settings
  • Others

By Region :

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Singapore
    • Australia
  • LAMEA
    • Brazil
    • Argentina
    • Egypt
    • Israel
    • South Africa
    • Rest of LAMEA

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements